✨ Classification of Medicines




4 NOVEMBER

NEW ZEALAND GAZETTE

3293

  • Sultamicillin; and its salts
  • Sumatriptan; and its salts
  • Tazobactam
  • T cell receptor antibody
  • Teicoplanin
  • Terazosin; and its salts
  • Terbinafine; except for external use
  • Thymoxamine; except when used by a registered optometrist in his practice
  • Tibolone
  • Ticlopidine; and its salts
  • Tolrestat
  • Torasemide
  • Trandolapril
  • Trazodone
  • Tretinoin
  • Triptorelin
  • Tropicamide; except when used by a registered optometrist in his practice
  • Trospisetron
  • Venlafaxine
  • Vigabatrin
  • Xamoterol
  • Zalcitabine
  • Zinc; and its salts; in medicines for internal use containing more than 25 mg of elemental zinc per recommended daily dose
  • Zuclopenthixol; and its salts and esters

Second Schedule

Restricted Medicines

  • Aciclovir; in medicines for external use; except in medicines for ophthalmological use

  • Alcohol, absolute; in medicines for internal and external use, except when compounded in a medicine

  • Aminacrine; and its salts; in medicines for external use

  • Amphotericin; for buccal use

  • Aspirin; in slow-release forms; in enteric-coated forms containing more than 300 mg per dose form

  • Bismuth; and its salts; in medicines for internal use

  • Beta 2-adrenoceptor agonists; except in medicines for inhalation or for parenteral use

  • Carbuterol; and its salts; except when contained in medicines for inhalation or for parenteral use

  • Ciclopirox; for dermatological use in medicines containing more than 1% of ciclopirox

  • Clindamycin; and its salts; in medicines for dermatological use

  • Clotrimazole; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

  • Cholestyramine resin

  • Cromoglycate sodium; for nasal administration

  • Diclofenac; and its salts; in tablets or capsules containing 25 mg or less and in pack sizes of no more than 30 tablets or capsules

  • Dithranol; and its esters

  • Econazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

  • Ether; except when used as a vehicle for a topical dose form

  • Ethyl chloride

  • Fenoterol; and its salts; except in medicines for inhalation or for parenteral use

  • Glycopyrronium; and its salts; except in medicines for parenteral use

  • Hexoprenaline; and its salts; except in medicines for inhalation or for parenteral use

  • Hydrocortisone; and hydrocortisone acetate; in dermatological medicines containing 1% or less and more than 0.5% by weight of hydrocortisone base with no other active ingredient except an antifungal and in a quantity of not more than 15 grams or 15 millilitres per container

  • Hydrocortisone; and hydrocortisone acetate; in rectal medicines in cream or ointment form containing 1% or less by weight of hydrocortisone base and in combination with a local anaesthetic and in a quantity of not more than 35 grams per container

  • Hyoscine; and its salts; in medicines for transdermal use and oral use

  • Hyoscine-N butyl bromide; in medicines for oral use

  • Hyoscyamine; and its salts; in medicines containing 0.15% and less of hyoscyamine; except in forms for parenteral use

  • Insulins

  • Isoconazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

  • Isoetharine; and its salts; except when contained in medicines for inhalation or for parenteral use

  • Ketoprofen; and its salts; in tablets or capsules containing 25 mg or less of ketoprofen and in pack sizes of not more than 30 tablets or capsules

  • Levocabastine

  • Mercury oxides

  • Mercury, ammoniated

  • Mercury; and its salts; and its compounds

  • Metoclopramide; when compounded with paracetamol and in a pack size of not more than six tablets or capsules

  • Miconazole; in medicines for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

  • Minoxidil; in medicines for external use

  • Mupirocin; and its salts

  • Natamycin; for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

  • Naproxen; and its salts; in tablets or capsules containing 250 mg or less of naproxen and in pack sizes of not more than 30 tablets or capsules

  • Nicotinamide; in medicines containing more than 100 mg per dose form

  • Nicotine; for nasal use

  • Nicotinic acid; in medicines containing more than 100 mg per dose form

  • Nicotinyl alcohol; in medicines containing more than 100 mg per dose form

  • Nitrite, butyl

  • Nitrite, isobutyl

  • Nitrite, octyl

  • Nystatin; in medicines for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

  • Orciprenaline; and its salts; in medicines for oral use

  • Papaverine; and its salts

  • Podophyllum; and extracts; tinctures of podophyllum; podophyllin; in medicines containing 20% or less of podophyllum

  • Pralidoxime; and its salts



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1993, No 161


NZLII PDF NZ Gazette 1993, No 161





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines under the Medicines Act 1981 (continued from previous page)

πŸ₯ Health & Social Welfare
27 October 1993
Medicines Act, Classification of Medicines, Prescription Medicines, Restricted Medicines, Pharmacy-Only Medicines, General Sale Medicines